Asensus Surgical, Inc. provided unaudited guidance For the quarter and full year ending on December 31, 2023. For the quarter, the company estimates preliminary unaudited revenue of approximately $5.1- $5.7 million.

For the full year, preliminary unaudited 2023 revenue is expected to be approximately $8.2 - $8.8 million, representing revenues from the sale of three Senhance Systems, multiple system leases, and related revenues from instruments, accessories, and services.